Leading Pharmaceutical Innovation
Leading Pharmaceutical Innovation
This book investigates and highlights the most critical challenges the pharmaceutical industry faces in an increasingly competitive environment of inflationary R&D investments and tightening cost control pressures. The authors present three sources of pharmaceutical innovation: new management methods in the drug development pipeline; new technologies as enablers for cutting-edge R&D; and new forms of cooperation and internationalization, such as open innovation in the early phases of R&D. New models and methods are illustrated with cases from Europe, the US, and Asia. This third fully revised edition was expanded to reflect the latest updates in open and collaborative innovation, the greater strategic importance of venture capital and early-stage investments, and the new range of emerging technologies now being put to use in pharmaceutical innovation.
Innovation: Key to Success in the Pharmaceutical Industry
The Industry Challenge: Who Would Want to Be in This Business?- The Science and Technology Challenge: How to Find New DrugsThe Pipeline Challenge: How to Organize Innovation
The Make-or-Buy Challenge: How to In- and Outsource Innovation
The Open Innovation Challenge: How to Partner for Innovation
The Internationalization Challenge: Where to Access Innovation
Future Directions and Trends.<br />
Gassmann, Oliver
Schuhmacher, Alexander
Zedtwitz, Max von
Reepmeyer, Gerrit
| ISBN | 978-3-030-09782-0 |
|---|---|
| Artikelnummer | 9783030097820 |
| Medientyp | Buch |
| Auflage | 3. Aufl. |
| Copyrightjahr | 2019 |
| Verlag | Springer, Berlin |
| Umfang | XV, 179 Seiten |
| Abbildungen | XV, 179 p. 41 illus., 3 illus. in color. |
| Sprache | Englisch |
